Yongqiang Li

Yongqiang Li, PhD has extensive work experience in the biopharmaceutical industry as well as in the field of education. Yongqiang is currently the CEO of Candoo Pharmatech Company Inc., where they established and leads a technology-driven biopharmaceutical company that provides CRDMO platform services. Yongqiang'srole involves accelerating product development and reducing new drug access costs. Prior to this, Yongqiang worked at Apotex Inc. as a Senior Scientific Leader and Scientific Leader. Yongqiang also served as a Scientist at the company. In addition, Yongqiang has experience in teaching and was a Course Instructor at the University of Toronto. Yongqiang also worked as a Part-time Faculty at Seneca College and a Teaching Assistant at the University of Toronto.

Yongqiang Li, PhD earned their Doctor of Philosophy (Ph.D.) in Pharmaceutics and Drug Delivery from the University of Toronto between 2003 and 2007. Prior to that, they completed a Master's degree in Pharmaceutical Science and Engineering and a Bachelor's degree in Pharmaceutical Science and Engineering from Sichuan University.